ATTO Technology, Inc.
Kurt Beyer has a diverse work experience spanning over several industries. Kurt began their career at The Daily Yomiuri in 1984 as a Feature Page Editor and Columnist, where they initiated the Weekend Page and received an award for their personal column. In 1988, they joined Vintage Imports as the Director of Wine Cellar & Distribution, where they successfully increased sales and reorganized distribution routes. Two years later, they moved on to Odyssey Incorporated as an International Marketing & Media Service executive, and during their tenure, they established Odyssey as the Japanese representative of the London International Advertising Awards. In 2003, Beyer worked as the General Manager at Chapman Development, where they led a team in enhancing pricing, marketing, and corporate image strategies. Currently, Beyer is the International Sales Manager at ATTO Technology, Inc, responsible for leading international sales and marketing efforts, executing marketing programs, and strategic planning. Kurt has achieved significant sales growth in Japan and overall Asia Pacific.
Kurt Beyer began their education at Chaminade University of Honolulu in 1979. It is not specified whether they completed a degree or field of study during their time there. Kurt then transferred to the University of San Francisco in 1982 and graduated in 1984 with a Bachelor of Arts degree in Mass Media, with a concentration in Broadcasting. Additionally, no specific information is provided about their enrollment or completion of a degree at St. Mary's International School in Tokyo, Japan. It is worth noting that there is some ambiguity in the information provided, as the final entry mentions "University of San" without specifying a location, but does indicate completion of a Bachelor of Arts degree in Mass Media.
This person is not in any offices
ATTO Technology, Inc.
Since 1985, Atto Bioscience (formerly Atto Instruments) has provided innovative solutions to pharmaceutical, academic, and research groups in cellular biology. Combining the proven expertise of its top scientists with its unique, flexible, and easily-integrated technology, Atto redefines cellular research and drug discovery with customized andinnovative approaches that enhance any research process.Atto’s key competitive advantage is the ability to integrate biology, imaging instrumentation, engineering, and manufacturing and to deliver to the life science, pharmaceutical and toxicology community a comprehensive offering of assays, instrumentation and services. Their in-house design and development of technology affords us a better understanding of application areas allowing us to adapt to the demands of their customers, and to quickly engineer and develop state-of-the-art imaging solutions to meet those demands.In the summer of 2001, Atto reorganized to expand into the drug discovery market place. As part of the reorganization Atto expanded their management and business teams and has doubled the size of the company over the last year.Atto also strengthened its scientific teams by bringing in some of the lead scientists in cell and molecular biology also from Life Technologies.These new personnel additions along with new venture money have allowed Atto to aggressively move into the high-throughput cell imaging marketplace. From secondary screening techniques to pre-clinical research, Atto technologies and expertise creates improved strategies for reducing time and increasing downstream success.